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Abstract
Background: Pulmonary veins (PVs) are the most important sources of ectopic beats with the initiation of paroxysmal 
atrial fibrillation, or the foci of ectopic atrial tachycardia and focal atrial fibrillation. Elimination of nitric oxide (NO) 
enhances cardiac triggered activity, and NO can decrease PV arrhythmogensis through mechano-electrical feedback. 
However, it is not clear whether NO may have direct electrophysiological effects on PV cardiomyocytes. This study is 
aimed to study the effects of nitroprusside (NO donor), on the ionic currents and arrhythmogenic activity of single 
cardiomyocytes from the PVs.
Methods: Single PV cardiomyocytes were isolated from the canine PVs. The action potential and ionic currents were 
investigated in isolated single canine PV cardiomyocytes before and after sodium nitroprusside (80 ?M,) using the 
whole-cell patch clamp technique.
Results: Nitroprusside decreased PV cardiomyocytes spontaneous beating rates from 1.7 ± 0.3 Hz to 0.5 ± 0.4 Hz in 9 
cells (P < 0.05); suppressed delayed afterdepolarization in 4 (80%) of 5 PV cardiomyocytes. Nitroprusside inhibited L-
type calcium currents, transient outward currents and transient inward current, but increased delayed rectified 
potassium currents.
Conclusion: Nitroprusside regulates the electrical activity of PV cardiomyocytes, which suggests that NO may play a 
role in PV arrhythmogenesis.
Background
A t r i a l  f i b r i l l a t i o n  ( A F )  i s  t h e  m o s t  c o m m o n  s u s t a i n e d
arrhythmia in clinical medicine. The pulmonary veins
(PVs) have been demonstrated to be an important source
of the initiation of AF [1,2] and also to have a role in the
maintenance of AF [3]. Previous anatomical and electro-
physiological study in isolated PVs specimen have dem-
onstrated that PVs contain a mixture of pacemaker cells
and working myocardium [4-9]. In canine PVs, we also
demonstrated that PVs have arrhythmogenic activity
through the enhancement of spontaneous activities or
high frequency irregular rhythms [10,11]. These findings
confirmed the previous observation in embryological
heart, whereas PVs were suggested to work as a subsid-
iary pacemaker [12]. Enhancement of automaticity and
triggered activity in PV cardiomyocytes with pacemaker
activity was suggested to play a critical role in the
pathophysiology of AF [10,11,13,14].
Previous studies have shown that nitric oxide (NO) has
important regulatory effects on the cardiovascular sys-
tem [15,16]. NO has been shown to have a role in the
development of triggered arrhythmias generated by
Ca2+overload [17]. Our previous study in vivo also
showed that NO could suppress trigged activity induced
ventricular tachycardia [18]. It is known that PVs contain
endothelium and smooth muscle which may produce NO
through the enzyme of eNOS or iNOS. In addition, car-
diac myocytes also express eNOS activity [19]. NO has
been shown to regulate PV arrhythmogensis through
mechano-electrical feedback [20]. Because PVs was
known to induce atrial arrhythmia through the enhance-
ment of triggered activity, it is possible that NO may play
a critical role in the PV arrhythmogenic activity. More-
over, perioperative administration of nitroprusside (NO
donor) during the rewarming period could prevent post-
operative AF in patients undergoing myocardial revascu-
larization, which suggests the anti-AF effects of
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nitroprusside [21]. However, it is not clear whether nitro-
prusside may have direct electrophysiological effects on
PV cardiomyocytes. Therefore, the purpose of this study
was to study the effects of nitroprusside on the ionic cur-
rents and arrhythmogenic activity of single PV cardio-
myocytes.
Materials and methods
Isolation of single cardiomyocytes
The investigation conformed to the institutional Guide
for the Care and Use of Laboratory Animals. Twenty-one
mongrel dogs were used in this study. After the dogs were
anesthetized with sodium pentobarbital (30 mg/kg, i.v.),
the hearts were rapidly removed through a thoracotomy
and dissected at room temperature in normal Tyrode
solution with the composition (in mM) of 137 NaCl; 4
KCl; 15 NaHCO3; 0.5 NaH2PO4; 0.5 MgCl2; 2.7 CaCl2,
and 11 dextrose. Tyrode solution was equilibrated with a
gas mixture of 97% O2 -3% CO2, with a pH of around 7.4.
For dissection of the PVs, the left atrium was opened by
an incision extending from the coronary sinus. The PVs
were separated from the left atrium about 5 mm proximal
to the junction between PVs and left atrium. The veins
were separated from the lung parenchyma through the
incisions about 20 mm distal to the ending of myocardial
sleeve. The isolated PVs were perfused from the distal
end with inside out of PVs through a polyethylene tubing.
The other end of the polyethylene tubing was connected
to a perfusion pump with a perfusion rate of 500 ml/hr.
The proximal end and side branches of PVs were ligated
with silk. The PVs were perfusated initially with oxygen-
ated normal Tyrode solution and replaced with Ca2+-free
Tyrode solution. The perfusate was replaced with oxy-
genated Ca2+-free Tyrode solution containing 3 units/ml
collagenase (Sigma Type I) and 0.5 units/ml protease
(Sigma, Type XIV). After softening of the PVs, the PVs
were cut into fine pieces and gently shaken in 5-10 ml of
Ca2+-free oxygenated Tyrode solution until single cardio-
myocytes were obtained. The solution was then gradually
changed to normal oxygenated Tyrode solution. Only
cells showing clear cross striations were used. Experi-
ments were carried out within the room temperature (34-
36°C). The cells were allowed to stabilize in the bath for at
least 30 min before experiments.
Electrophysiological and pharmacological study
Whole-cell patch-clamp was performed in cardiomyo-
c y t e s  b y  m e a n s  o f  a n  A x o p a t c h  1 D  a m p l i f i e r  ( A x o n
Instruments, Calif, USA) at 35 ± 1°C. Borosilicate glass
electrodes (o.d., 1.8 mm) were used, with tip resistances
of 3-5 M?. Before formation of the membrane-pipette
seal, tip potentials were zeroed in Tyrode solution. Junc-
tion potentials (9 mV) were corrected for action poten-
tials (APs) recording. AP and transient inward currents
were measured during superfusion with normal Tyrode
solution, pipette solution contained (in mM): KCl 20, K
aspartate 110, MgCl2 1, Mg2ATP 5, HEPES 10, EGTA 0.5,
and LiGTP 0.1, Na2phosphocreatine 5, adjusted to pH 7.2
with 1 N KOH. The APs were recorded in current-clamp
mode and ionic currents in voltage-clamp mode as
described previously [11]. A small hyperpolarizing step
from a holding potential of -50 mV to a testing potential
of -55 mV for 80 ms was delivered at the beginning of
each experiment. The area under the capacitative cur-
rents was divided by the applied voltage step to obtain the
total cell capacitance of 36 ± 3 pF in 43 PV cardiomyo-
cytes. Normally, 60% to 80% series resistance (Rs) was
electronically compensated. AP measurements were
begun at 5 minutes after cell rupture. The 50% (APD50)
and 90% (APD90) of the AP duration were measured dur-
ing 1 Hz electrical stimulation in the PV cardiomyocytes.
Micropipettes were filled with a solution containing (in
mM) CsCl 130, MgCl2 1, Mg2ATP 5, HEPES 10, EGTA 10,
NaGTP 0.1, and Na2 phosphocreatine 5, titrated to a pH
of 7.2 with CsOH for the experiments on the L-type cal-
cium current (ICa-L). The micropipettes were filled with a
solution containing (in mM) KCl 20, K aspartate 110,
MgCl2 1, Mg2ATP 5, HEPES 10, EGTA 0.5, LiGTP 0.1,
and Na2 phosphocreatine 5, titrated to a pH of 7.2 with
KOH for the experiments on the APs, potassium cur-
rents, and transient inward currents. Voltage command
pulses were generated by a 12-bit digital-to-analog con-
v e r t e r  c o n t r o l l e d  b y  p C L A M P  s o f t w a r e  ( A x o n  I n s t r u -
ments). Recordings were low pass-filtered at half the
sampling frequency.
The ICa-L was measured as an inward current during
depolarization from a holding potential of -50 mV to test-
ing potentials ranging from -40 to +60 mV in 10-mV steps
for 300 ms at a frequency of 0.1 Hz. The NaCl and KCl in
the external solution were replaced by tetraethylammo-
nium chloride and CsCl, respectively.
The transient outward current (Ito) was studied with a
double-pulse protocol. A 30-ms pre-pulse from -80 to -40
mV was used to inactivate the sodium channels, followed
by a 300-ms test pulse to +60 mV in 10-mV steps at a fre-
quency of 0.1 Hz. CdCl2 (200 ?M) was added to the bath
solution to inhibit the ICa-L. The Ito was measured as the
difference between the peak outward current and steady-
state current. The sustained outward potassium currents
(IKsus) were measured as the outward current density at
the end of the steady state.
The delayed rectified outward potassium current (IK)
was measured from the peak outward current at the end
of 1 s and the depolarization from -40 to +60 mV in 10-
mV steps at a frequency of 0.1 Hz during the infusion ofLin et al. Journal of Biomedical Science 2010, 17:20
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CdCl2 (200 ?M) and 4-aminopyridine (2 mM) in the bath
solution.
Transient inward current was induced at clamped
potentials from -40 to +40 mV for the duration of 2 sec
and then repolarized to -40 mV. The amplitude of tran-
sient inward current was measured as difference between
the peak of the transient current and the mean of current
just before and after the transient current.
Statistics
All quantitative data are expressed as mean ± SE. The dif-
ferences between before and after drugs administration
were analyzed by Wilcoxon signed-rank test. A P value
lower than 0.05 was considered to be statistically signifi-
cant.
Results
Effects of nitroprusside on arrhythmogenic activity of PV 
cardiomyocytes
Nine PV cardiomyocytes with pacemaker activity
received the administration of 80 ?M nitroprusside.
Nitroprusside decreased PV cardiomyocytes spontane-
ous beating rates from 1.7 ± 0.3 Hz to 0.5 ± 0.4 Hz in 9
cells (P < 0.05). Figure 1 shows the example that PV cardi-
omyocytes spontaneous activity was suppressed from to
after the administration of nitroprusside. In addition,
nitroprusside inhibited delayed afterdepolarization in 4
(80%) of 5 PV cardiomyocytes. The amplitude of delayed
afterdepolarization was suppressed from 9 ± 2 to 4 ± 2
mV. Figure 2 shows the example of the changes of delayed
afterdepolarization after nitroprusside.
Figure 3 shows the effects of nitroprusside on AP mor-
phology in the PV cardiomyocytes, nitroprusside (80 ?M)
shortened the 90% and 50% of the AP duration. Figure 1
shows the example of AP before and after the administra-
tion of nitroprusside. However, nitroprusside did not
change the resting membrane potential in these cardio-
myocytes.
Effects of nitroprusside on ionic currents of PV 
cardiomyocytes
As the example shown in Figure 4, nitroprusside can
decrease the ICa-L in PV cardiomyocytes. Moreover, nitro-
prusside can decrease the Ito in PV cardiomyocytes, but
increase the IKsus (Figure 5). Figure 6 shows the current
traces and I-V relationship of IK in PV cardiomyocytes
before and after the administration of nitroprusside.
Nitroprusside enhanced IK in PV cardiomyocytes. Figure
7 shows the tracing of transient inward current before
and after the administration of nitroprusside, whereas
nitroprusside inhibited transient inward current from
Figure 1 Spontaneous activity before (upper panel) and after 
(lower panel) the administration of nitroprusside. Nitroprusside 
suppressed the spontaneous activity in a pulmonary vein (PV) cardio-
myocyte.
Figure 2 Effect of nitroprusside on the PV delayed after depolar-
ization. Delayed afterdepolarization (indicated by arrow) in a PV cardi-
omyocyte was suppressed after (lower panel) the administration of 
nitroprusside.Lin et al. Journal of Biomedical Science 2010, 17:20
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0.74 ± 0.13 pA/pF to 0.29 ± 0.09 pA/pF (n = 13, P <
0.001).
Discussion
In this study, for the first time, we demonstrated that
nitroprusside can directly suppress the spontaneous
activity, inhibit delayed afterdepolarization with the
decreases of transient inward currents in PV cardiomyo-
cytes. NO has been shown to change automaticity in
sinoatrial cell [22] and also been found to have lower
plasma NO levels in the patients with AF than subjects
with sinus rhythm [23]. These findings suggested that NO
may be associated with the occurrence of AF. Previous
studies have shown that PVs play a critical role in the gen-
esis of atrial fibrillation. Our studies further showed that
PVs have a high arrhythmogenic activity through the
Figure 3 Effect of nitroprusside on the PV electrical activity. Action potential of PV cardiomyocyte before (indicated by black triangle) and after 
(indicated by blank triangle) the administration of nitroprusside. There were shorter action potentials after the administration of nitroprusside. *P < 
0.05, versus before nitroprusside PV cardiomyocytes. (RMP: resting membrane potential, APA: action potential amplitude, APD50: 50% of action poten-
tial duration, APD90: 90% of action potential duration).Lin et al. Journal of Biomedical Science 2010, 17:20
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enhancement of automaticity and triggered activity
[11,13,14]. In this study, we demonstrated that NO could
inhibit PV cardiomyocytes spontaneous activity and also
suppressed triggered activity from DAD. These findings
confirmed that NO has a role in the PV arrhythmogenic
activity.
NO have been shown to alter intracellular Ca2+ homeo-
stasis or inhibit both L-type Ca2+ currents and the stimu-
lation of L-type Ca2+ currents by ?-adrenergic agonists
[24-26]. Action of NOS3 has been shown to produce NO
to enhance Ca2+  sensitivity of the slowly activating
delayed rectified potassium current with the shortening
of AP duration in guinea pig ventricular cardiomyocytes
Figure 4 The current tracings and I-V relationship of the L-type calcium current (ICa-L) of the control and nitroprusside-treated PV cardio-
myocytes (n = 6). The ICa-L in the nitroprusside-treated PV cardiomyocytes was smaller than that in the control PV cardiomyocytes. The insets of the 
current tracings show the various clamp protocols. *P < 0.05, **P < 0.01, versus before nitroprusside PV cardiomyocytes.Lin et al. Journal of Biomedical Science 2010, 17:20
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[27]. Similarly, this study found that direct administration
of NO donor can decrease ICa-L, which may contribute to
the shortening of AP duration and the decreases of PV
spontaneous activity and triggered activity. Previous
studies have indicated the importance of calcium homeo-
stasis in PV electrical activity [28-30] and transient
inward current plays an important role in the genesis of
PV arrhythmogenesis [11,13,14]. In this study, we dem-
onstrated that NO suppress transient inward currents,
which may result in the suppression of triggered activity
in PV cardiomyocytes. IKur has been found in atrial or PV
c a r d i o m y o c y t e s .  I n  t h i s  s t u d y ,  w e  m e a s u r e d  t h e  I Ksus
because the current density and I-V relationship of IKsus
and IKur are quite similar [31], and found an increase of
the IKsus after administration of nitroprusside, which may
result in the shortening of AP duration in PV cardiomyo-
cytes. Moreover, nitroprusside increase the IK also can
shorten the AP duration in PV cardiomyocytes.
Potential limitations
The data in this study should be interpreted with caution
due to the potential limitations. Only single dosage of
nitroprusside was used in this study. It is not clear
whether nitroprusside has concentration-dependent
effects on the PVs. Additionally, although nitroprusside is
considered to be NO donor, without the use of NO scav-
enger to reduce or reverse the effects of nitroprusside, we
may not exclude the possibility that our findings may not
be NO relevant. Moreover, NO signaling in cardiac mus-
cle was reported to be caused by the stimulation of gua-
nylate cyclase/cGMP production or nitrosylation of
sulfhydryl groups on cystein residue of channel protein
[32,33]. However, this study did not investigate the
molecular mechanisms underlying the ionic effects of
nitroprusside on PV cardiomyocytes.
Conclusions
Nitroprusside has significant effects on regulating the
arrhythmogenic activity of PV cardiomyocytes, which
suggests that NO may play a role in PV arrhythmogene-
sis.
Figure 5 Effects of nitroprusside on the transient outward current (Ito) and sustained outward potassium currents (IKsus) in the PV cardio-
myocytes (n = 6). Upper and lower panel shows the current tracings and I-V relationship of the Ito of before and after the administration of nitroprus-
side in PV cardiomyocytes. The Ito in the nitroprusside-treated PV cardiomyocytes was smaller than that in the control PV cardiomyocytes. Lower panel 
shows the current tracings and I-V relationship of the IKsus before and after the administration of nitroprusside in PV cardiomyocytes. The IKsus was larger 
in the nitroprusside-treated PV cardiomyocytes than that in the control PV cardiomyocytes. The insets of the current traces show the various clamp 
protocols. *P < 0.05, **P < 0.01, versus before nitroprusside PV cardiomyocytes.Lin et al. Journal of Biomedical Science 2010, 17:20
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Figure 6 Effect of nitroprusside on delayed rectified outward potassium current (IK) in the PV cardiomyocytes (n = 11). Current traces (upper 
panel) and I-V relationship (lower panel) of IK in the PV cardiomyocytes. Insets show the various clamp protocols. *P < 0.05, **P < 0.01, ***P < 0.005, 
versus before nitroprusside PV cardiomyocytes.Lin et al. Journal of Biomedical Science 2010, 17:20
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